FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrew Mazar

Research Profile

Chemicals & Drugs

Anatomy

Living Beings

Mouse

Disorders

Physiology

Phenomena

Protein Binding

Concepts & Ideas

Protein Structure, Tertiary

Co-author Network

Publications

TOP 3
Torry A Tucker; LaTerrica Williams; Timothy Craig Allen; Khalil Bdeir; Galina Florova; Kathy Koenig; Andrey A Komissarov; Hema Kothari; Andrew P Mazar; L Vijaya Mohan Rao; Steven Idell
Lipoprotein receptor-related protein 1 regulates collagen 1 expression, proteolysis, and migration in human pleural mesothelial cells.
Shafaat A Rabbani; Bushra Ateeq; Ani Arakelian; Maria Luisa Valentino; David E Shaw; Lisa M Dauffenbach; Christopher A Kerfoot; Andrew P Mazar
An anti-urokinase plasminogen activator receptor antibody (ATN-658) blocks prostate cancer invasion, migration, growth, and experimental skeletal metastasis in vitro and in vivo.
Guy Bloch; Tiago M Francoy; Ido Wachtel; Nava Panitz-Cohen; Stefan Fuchs; Andrew P Mazar
Industrial apiculture in the Jordan valley during Biblical times with Anatolian honeybees.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrew Mazar (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Torry A Tucker; LaTerrica Williams; Timothy Craig Allen; Khalil Bdeir; Galina Florova; Kathy Koenig; Andrey A Komissarov; Hema Kothari; Andrew P Mazar; L Vijaya Mohan Rao; Steven Idell
Lipoprotein receptor-related protein 1 regulates collagen 1 expression, proteolysis, and migration in human pleural mesothelial cells.
American journal of respiratory cell and molecular biology 2012;46(2):196-206.
2010: Shafaat A Rabbani; Bushra Ateeq; Ani Arakelian; Maria Luisa Valentino; David E Shaw; Lisa M Dauffenbach; Christopher A Kerfoot; Andrew P Mazar
An anti-urokinase plasminogen activator receptor antibody (ATN-658) blocks prostate cancer invasion, migration, growth, and experimental skeletal metastasis in vitro and in vivo.
Neoplasia (New York, N.Y.) 2010;12(10):778-88.
2010: Guy Bloch; Tiago M Francoy; Ido Wachtel; Nava Panitz-Cohen; Stefan Fuchs; Andrew P Mazar
Industrial apiculture in the Jordan valley during Biblical times with Anatolian honeybees.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(25):11240-4.
2010: Torry A Tucker; Candice Dean; Andrey A Komissarov; Kathy Koenig; Andrew P Mazar; Usha R Pendurthi; Timothy Allen; Steven Idell
The urokinase receptor supports tumorigenesis of human malignant pleural mesothelioma cells.
American journal of respiratory cell and molecular biology 2010;42(6):685-96.
2009: Valerie Trapp; Fernando Doñate; Kristy Lee; Andrew P Mazar; John P Fruehauf
Redox-related antimelanoma activity of ATN-224.
Melanoma research 2009;19(6):350-60.
2009: Andrey A Komissarov; Andrew P Mazar; Kathy Koenig; Anna K Kurdowska; Steven Idell
Regulation of intrapleural fibrinolysis by urokinase-alpha-macroglobulin complexes in tetracycline-induced pleural injury in rabbits.
American journal of physiology. Lung cellular and molecular physiology 2009;297(4):L568-77.
2009: George van Buren; Michael J Gray; Nikolaos A Dallas; Ling Xia; Sherry J Lim; Fan Fan; Andrew P Mazar; Lee M Ellis
Targeting the urokinase plasminogen activator receptor with a monoclonal antibody impairs the growth of human colorectal cancer in the liver.
Cancer 2009;115(14):3360-8.
2008: Andrew P Mazar
Urokinase plasminogen activator receptor choreographs multiple ligand interactions: implications for tumor progression and therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(18):5649-55.
2008: Jose C Juarez; Mari Manuia; Mark E Burnett; Oscar Betancourt; Benoit Boivin; David E Shaw; Nicholas K Tonks; Andrew P Mazar; Fernando Doñate
Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(20):7147-52.
2008: Fernando Doñate; Graham C Parry; Yuval Shaked; Harvey Hensley; Xiaojun Guan; Ivy Beck; Ziva Tel-Tsur; Marian L Plunkett; Mari Manuia; David E Shaw; Robert S Kerbel; Andrew P Mazar
Pharmacology of the novel antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2): observation of a U-shaped dose-response curve in several preclinical models of angiogenesis and tumor growth.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(7):2137-44.
2008: Qing Huai; Aiwu Zhou; Lin Lin; Andrew P Mazar; Graham C Parry; Jennifer Callahan; David E Shaw; Bruce Furie; Barbara C Furie; Mingdong Huang
Crystal structures of two human vitronectin, urokinase and urokinase receptor complexes.
Nature structural & molecular biology 2008;15(4):422-3.
2008: Fernando Doñate; Jose C Juarez; M E Burnett; M M Manuia; Xiaojun Guan; David E Shaw; E L P Smith; C Timucin; M J Braunstein; O A Batuman; Andrew P Mazar
Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224).
British journal of cancer 2008;98(4):776-83.
2007: Shafaat A Rabbani; Andrew P Mazar
Evaluating distant metastases in breast cancer: from biology to outcomes.
Cancer metastasis reviews 2007;26(3-4):663-74.
2007: Steven Idell; Ali O Azghani; Shande Chen; Kathy Koenig; Andrew P Mazar; Lalitha Kodandapani; Khalil Bdeir; Douglas B Cines; Irina Kulikovskaya; Timothy Allen
Intrapleural low-molecular-weight urokinase or tissue plasminogen activator versus single-chain urokinase in tetracycline-induced pleural loculation in rabbits.
Experimental lung research 2007;33(8-9):419-40.
2007: Sreerama Shetty; Thirunavukkarasu Velusamy; Steven Idell; Praveenkumar Shetty; Andrew P Mazar; Yashodhar P Bhandary; Rashmi S Shetty
Regulation of urokinase receptor expression by p53: novel role in stabilization of uPAR mRNA.
Molecular and cellular biology 2007;27(16):5607-18.
2007: Silvio Danese; Miquel Sans; David M Spencer; Ivy Beck; Fernando Doñate; Marian L Plunkett; Carol de la Motte; Raymond W Redline; David E Shaw; Alan D Levine; Andrew P Mazar; Claudio Fiocchi
Angiogenesis blockade as a new therapeutic approach to experimental colitis.
Gut 2007;56(6):855-62.
2007: Yongdong Li; Graham Parry; Liqing Chen; Jennifer A Callahan; David E Shaw; Edward J Meehan; Andrew P Mazar; Mingdong Huang
An anti-urokinase plasminogen activator receptor (uPAR) antibody: crystal structure and binding epitope.
Journal of molecular biology 2007;365(4):1117-29.
2007: Steven Idell; Timothy Allen; Shande Chen; Kathy Koenig; Andrew P Mazar; Ali O Azghani
Intrapleural activation, processing, efficacy, and duration of protection of single-chain urokinase in evolving tetracycline-induced pleural injury in rabbits.
American journal of physiology. Lung cellular and molecular physiology 2007;292(1):L25-32.
2006: John H Chidlow; Will Langston; James J M Greer; Dmitry V Ostanin; Maisoun Abdelbaqi; Jeffery Houghton; Annamalai Senthilkumar; Deepti Shukla; Andrew P Mazar; Matthew B Grisham; Christopher Kevil
Differential angiogenic regulation of experimental colitis.
The American journal of pathology 2006;169(6):2014-30.
2006: Cyril Barinka; Graham Parry; Jennifer Callahan; David E Shaw; Alice Kuo; Khalil Bdeir; Douglas B Cines; Andrew P Mazar; Jacek Lubkowski
Structural basis of interaction between urokinase-type plasminogen activator and its receptor.
Journal of molecular biology 2006;363(2):482-95.
2006: Parisa Khalili; Ani Arakelian; Gaoping Chen; Marian L Plunkett; Ivy Beck; Graham C Parry; Fernando Doñate; David E Shaw; Andrew P Mazar; Shafaat A Rabbani
A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo.
Molecular cancer therapeutics 2006;5(9):2271-80.
2006: Jose C Juarez; Oscar Betancourt; Steven R Pirie-Shepherd; Xiaojun Guan; Melissa L P Price; David E Shaw; Andrew P Mazar; Fernando Doñate
Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(16):4974-82.
2006: Mary Cianfrocca; K A Kimmel; James Gallo; T Cardoso; M M Brown; Gary R Hudes; Nancy Lewis; L Weiner; G N Lam; S C Brown; David E Shaw; Andrew P Mazar; Roger B Cohen
Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumours.
British journal of cancer 2006;94(11):1621-6.
2006: Takehiko Tarui; Nobuaki Akakura; Mousumi Majumdar; Nicholas M Andronicos; Junichi Takagi; Andrew P Mazar; Khalil Bdeir; Alice Kuo; Serge V Yarovoi; Douglas B Cines; Yoshikazu Takada
Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation.
Thrombosis and haemostasis 2006;95(3):524-34.
2006: Qing Huai; Andrew P Mazar; Alice Kuo; Graham C Parry; David E Shaw; Jennifer Callahan; Yongdong Li; Cai Yuan; Chuanbing Bian; Liqing Chen; Bruce Furie; Barbara C Furie; Douglas B Cines; Mingdong Huang
Structure of human urokinase plasminogen activator in complex with its receptor.
Science (New York, N.Y.) 2006;311(5761):656-9.
2005: Yongdong Li; Xiaoli Shi; Graham Parry; Liqing Chen; Jennifer A Callahan; Andrew P Mazar; Mingdong Huang
Optimization of crystals of an inhibitory antibody of urokinase plasminogen activator receptor (uPAR) with hydrogen peroxide and low protein concentration.
Protein and peptide letters 2005;12(7):655-8.
2005: Todd W. Bauer; Wenbiao Liu; Fan Fan; Ernest Ramsay Camp; Anthony Yang; Ray Somcio; Corazon D Bucana; Jennifer Callahan; Graham C Parry; Douglas B Evans; Douglas D Boyd; Andrew P Mazar; Lee M Ellis
Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Cancer research 2005;65(17):7775-81.
2005: Sreerama Shetty; Margaret R Gyetko; Andrew P Mazar
Induction of p53 by urokinase in lung epithelial cells.
The Journal of biological chemistry 2005;280(30):28133-41.
2005: Mingdong Huang; Andrew P Mazar; Graham Parry; Abd Al-Roof Higazi; Alice Kuo; Douglas B Cines
Crystallization of soluble urokinase receptor (suPAR) in complex with urokinase amino-terminal fragment (1-143).
Acta crystallographica. Section D, Biological crystallography 2005;61(Pt 6):697-700.
2005: Todd W. Bauer; Fan Fan; Wenbiao Liu; Marjorie Johnson; Nila U Parikh; Graham C Parry; Jennifer Callahan; Andrew P Mazar; Gary E Gallick; Lee M Ellis
Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.
Annals of surgery 2005;241(5):748-56; discussion 756-8.
2004: Fernando Doñate; Keith R McCrae; David E Shaw; Andrew P Mazar
Extracellular tropomyosin: a novel common pathway target for anti-angiogenic therapy.
Current cancer drug targets 2004;4(7):543-53.
2004: Fernando Doñate; Jose C Juarez; Xiaojun Guan; Natalya V Shipulina; Marian L Plunkett; Ziva Tel-Tsur; David E Shaw; William T Morgan; Andrew P Mazar
Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities.
Cancer research 2004;64(16):5812-7.
2004: Xiaojun Guan; Jose C Juarez; Xiaoping Qi; Natalya V Shipulina; David E Shaw; William T Morgan; Keith R McCrae; Andrew P Mazar; Fernando Doñate
Histidine-proline rich glycoprotein (HPRG) binds and transduces anti-angiogenic signals through cell surface tropomyosin on endothelial cells.
Thrombosis and haemostasis 2004;92(2):403-12.
2004: Christopher L Hall; Rachel Tsan; Gabriele Mugnai; Andrew P Mazar; Robert Radinsky; Curtis A Pettaway
Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA).
The Prostate 2004;59(2):167-76.
2003: Dae-Il Chang; Naohisa Hosomi; Jacinta Lucero; Ji Hoe Heo; Takeo Abumiya; Andrew P Mazar; Gregory J del Zoppo
Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2003;23(12):1408-19.
2003: Khalil Bdeir; Alice Kuo; Bruce S Sachais; Ann H Rux; Yasmina Bdeir; Andrew P Mazar; Abd Al-Roof Higazi; Douglas B Cines
The kringle stabilizes urokinase binding to the urokinase receptor.
Blood 2003;102(10):3600-8.
2003: Takehiko Tarui; Nicholas M Andronicos; Ralf-Peter Czekay; Andrew P Mazar; Khalil Bdeir; Graham C Parry; Alice Kuo; David J Loskutoff; Douglas B Cines; Yoshikazu Takada
Critical role of integrin alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling.
The Journal of biological chemistry 2003;278(32):29863-72.
2003: Oliver Stoeltzing; Wenbiao Liu; Niels Reinmuth; Fan Fan; Graham C Parry; Alexander A Parikh; Marya F McCarty; Corazon D Bucana; Andrew P Mazar; Lee M Ellis
Inhibition of integrin alpha5beta1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice.
International journal of cancer. Journal international du cancer 2003;104(4):496-503.
2002: Anjuli Datta; Richard P Kitson; Yaming Xue; Gheath Al-Atrash; Andrew P Mazar; Terence R Jones; Ronald H Goldfarb
Combined chemo/anti-angiogenic cancer therapy against Lewis lung carcinoma (3LL) pulmonary metastases.
In vivo (Athens, Greece) 2002;16(6):451-7.
2002: Taher Nassar; Abdullah Haj-Yehia; Sa'ed Akkawi; Alice Kuo; Khalil Bdeir; Andrew P Mazar; Douglas B Cines; Abd Al-Roof Higazi
Binding of urokinase to low density lipoprotein-related receptor (LRP) regulates vascular smooth muscle cell contraction.
The Journal of biological chemistry 2002;277(43):40499-504.
2002: Steven Idell; Andrew P Mazar; Douglas B Cines; Alice Kuo; Graham Parry; Susan Gawlak; Jose Juarez; Kathy Koenig; Ali O Azghani; Will Hadden; Jerry McLarty; Edmund Miller
Single-chain urokinase alone or complexed to its receptor in tetracycline-induced pleuritis in rabbits.
American journal of respiratory and critical care medicine 2002;166(7):920-6.
2002: Jing-Chuan Zhang; Fernando Donate; Xiaoping Qi; Nicholas P Ziats; Jose C Juarez; Andrew P Mazar; Yuan-Ping Pang; Keith R McCrae
The antiangiogenic activity of cleaved high molecular weight kininogen is mediated through binding to endothelial cell tropomyosin.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(19):12224-9.
2002: Jose C Juarez; Xiaojun Guan; Natalya V Shipulina; Marian L Plunkett; Graham C Parry; David E Shaw; Jing-Chuan Zhang; Shafaat A Rabbani; Keith R McCrae; Andrew P Mazar; William T Morgan; Fernando Doñate
Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain.
Cancer research 2002;62(18):5344-50.
2002: YongJing Guo; Andrew P Mazar; Jean-Jacques Lebrun; Shafaat A Rabbani
An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
Cancer research 2002;62(16):4678-84.
2002: Jing-Chuan Zhang; Xiaoping Qi; Jose C Juarez; Marian Plunkett; Fernando Donaté; Ramasamy Sakthivel; Andrew P Mazar; Keith R McCrae
Inhibition of angiogenesis by two-chain high molecular weight kininogen (HKa) and kininogen-derived polypeptides.
Canadian journal of physiology and pharmacology 2002;80(2):85-90.
2001: Gheath Al-Atrash; Richard P Kitson; Yaming Xue; Andrew P Mazar; Myoung H Kim; Ronald H Goldfarb
uPA and uPAR contribute to NK cell invasion through the extracellular matrix.
Anticancer research 2001;21(3B):1697-704.
2001: Shafaat A Rabbani; Andrew P Mazar
The role of the plasminogen activation system in angiogenesis and metastasis.
Surgical oncology clinics of North America 2001;10(2):393-415, x.
2001: Takehiko Tarui; Andrew P Mazar; Douglas B Cines; Yoshikazu Takada
Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interaction.
The Journal of biological chemistry 2001;276(6):3983-90.
2001: Steven Idell; Andrew P Mazar; P Bitterman; S Mohla; A L Harabin
Fibrin turnover in lung inflammation and neoplasia.
American journal of respiratory and critical care medicine 2001;163(2):578-84.
2000: Khalil Bdeir; Alice Kuo; Andrew P Mazar; Bruce S Sachais; W Xiao; Susan Gawlak; S Harris; Abd Al-Roof Higazi; Douglas B Cines
A region in domain II of the urokinase receptor required for urokinase binding.
The Journal of biological chemistry 2000;275(37):28532-8.
2000: O Shliom; M Huang; Bruce S Sachais; Alice Kuo; John W Weisel; Chandrasekaran Nagaswami; Taher Nassar; Khalil Bdeir; Edna Hiss; Susan Gawlak; S Harris; Andrew P Mazar; Abd Al-Roof Higazi
Novel interactions between urokinase and its receptor.
The Journal of biological chemistry 2000;275(32):24304-12.
2000: Abdullah Haj-Yehia; Taher Nassar; Bruce S Sachais; Alice Kuo; Khalil Bdeir; Abu-Bakr Al-Mehdi; Andrew P Mazar; Douglas B Cines; Abd Al-Roof Higazi
Urokinase-derived peptides regulate vascular smooth muscle contraction in vitro and in vivo.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2000;14(10):1411-22.
2000: Y Guo; Abd Al-Roof Higazi; Ani Arakelian; Bruce S Sachais; D Cines; R H Goldfarb; T R Jones; H Kwaan; Andrew P Mazar; Shafaat A Rabbani
A peptide derived from the nonreceptor binding region of urokinase plasminogen activator (uPA) inhibits tumor progression and angiogenesis and induces tumor cell death in vivo.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2000;14(10):1400-10.
1999: Heike Allgayer; Hua Wang; Gary E Gallick; A Crabtree; Andrew P Mazar; T Jones; Alan J Kraker; Douglas D Boyd
Transcriptional induction of the urokinase receptor gene by a constitutively active Src. Requirement of an upstream motif (-152/-135) bound with Sp1.
The Journal of biological chemistry 1999;274(26):18428-37.
1999: Andrew P Mazar; Jack Henkin; R H Goldfarb
The urokinase plasminogen activator system in cancer: implications for tumor angiogenesis and metastasis.
Angiogenesis 1999;3(1):15-32.
1997: Robert W Colman; Robin A Pixley; S Najamunnisa; W Yan; J Wang; Andrew P Mazar; Keith R McCrae
Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor.
The Journal of clinical investigation 1997;100(6):1481-7.
1997: Rosie Hongmei Xing; Andrew P Mazar; Jack Henkin; Shafaat A Rabbani
Prevention of breast cancer growth, invasion, and metastasis by antiestrogen tamoxifen alone or in combination with urokinase inhibitor B-428.
Cancer research 1997;57(16):3585-93.
1997: Shafaat A Rabbani; Julienne Gladu; Andrew P Mazar; Jack Henkin; David Goltzman
Induction in human osteoblastic cells (SaOS2) of the early response genes fos, jun, and myc by the amino terminal fragment (ATF) of urokinase.
Journal of cellular physiology 1997;172(2):137-45.
1997: J Wang; Andrew P Mazar; N Quan; Andrew Schneider; Jack Henkin
Plasminogen activation by pro-urokinase in complex with its receptor--dependence on a tripeptide (Spectrozyme plasmin).
European journal of biochemistry / FEBS 1997;247(1):256-61.
1997: Alissa M Weaver; Isa M Hussaini; Andrew P Mazar; Jack Henkin; Steven L Gonias
Embryonic fibroblasts that are genetically deficient in low density lipoprotein receptor-related protein demonstrate increased activity of the urokinase receptor system and accelerated migration on vitronectin.
The Journal of biological chemistry 1997;272(22):14372-9.
1997: Abd Al-Roof Higazi; Andrew P Mazar; Jing Wang; N Quan; R Griffin; R Reilly; Jack Henkin; Douglas B Cines
Soluble human urokinase receptor is composed of two active units.
The Journal of biological chemistry 1997;272(8):5348-53.
1996: Abd Al-Roof Higazi; Andrew P Mazar; J Wang; R Reilly; Jack Henkin; D Kniss; Douglas B Cines
Single-chain urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1.
Blood 1996;87(9):3545-9.
1995: Shafaat A Rabbani; P Harakidas; D J Davidson; Jack Henkin; Andrew P Mazar
Prevention of prostate-cancer metastasis in vivo by a novel synthetic inhibitor of urokinase-type plasminogen activator (uPA).
International journal of cancer. Journal international du cancer 1995;63(6):840-5.
1995: H W Schnaper; Elliot S Barnathan; Andrew P Mazar; S Maheshwari; S Ellis; S L Cortez; William H Baricos; Hynda K Kleinman
Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways.
Journal of cellular physiology 1995;165(1):107-18.
1994: Hinke A B Multhaupt; Andrew P Mazar; Douglas B Cines; MJ Warhol; Keith R McCrae
Expression of urokinase receptors by human trophoblast. A histochemical and ultrastructural analysis.
Laboratory investigation; a journal of technical methods and pathology 1994;71(3):392-400.
1994: Alexandra L Howell; J A Hunt; T W James; Andrew P Mazar; J Henkin; Leo R Zacharski
Urokinase inhibits HL-60 cell proliferation in vitro.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1994;5(4):445-53.
1994: A P Hansen; Andrew M Petros; Robert P Meadows; D G Nettesheim; Andrew P Mazar; Edward T Olejniczak; R X Xu; T M Pederson; Jack Henkin; Stephen W Fesik
Solution structure of the amino-terminal fragment of urokinase-type plasminogen activator.
Biochemistry 1994;33(16):4847-64.
1993: S Zhang; M Laurent; R Lopez-Alemany; Andrew P Mazar; J Henkin; E Ronne; P Burtin
Comparative localization of receptors for plasmin and for urokinase on MCF 7 cells.
Experimental cell research 1993;207(2):290-9.
1993: G Clayman; S W Wang; Garth L Nicolson; A el-Naggar; Andrew P Mazar; Jack Henkin; F Blasi; H Goepfert; D D Boyd
Regulation of urokinase-type plasminogen activator expression in squamous-cell carcinoma of the oral cavity.
International journal of cancer. Journal international du cancer 1993;54(1):73-80.
1992: A P Hansen; Andrew M Petros; Andrew P Mazar; T M Pederson; A Rueter; Stephen W Fesik
A practical method for uniform isotopic labeling of recombinant proteins in mammalian cells.
Biochemistry 1992;31(51):12713-8.
1992: W Hollas; N Hoosein; Leland W K Chung; Andrew P Mazar; Jack Henkin; Katalin Kariko; Elliot S Barnathan; D Boyd
Expression of urokinase and its receptor in invasive and non-invasive prostate cancer cell lines.
Thrombosis and haemostasis 1992;68(6):662-6.
1992: W Hollas; E Soravia; Andrew P Mazar; Jack Henkin; F Blasi; D Boyd
Decreased urokinase receptor expression by overexpression of the plasminogen activator in a colon cancer cell line.
The Biochemical journal 1992;285 ( Pt 2)():629-34.
1992: Shafaat A Rabbani; Andrew P Mazar; S M Bernier; M Haq; I Bolivar; Jack Henkin; David Goltzman
Structural requirements for the growth factor activity of the amino-terminal domain of urokinase.
The Journal of biological chemistry 1992;267(20):14151-6.
1992: J M Zini; S C Murray; Charles H Graham; P K Lala; Katalin Karikó; Elliot S Barnathan; Andrew P Mazar; Jack Henkin; Douglas B Cines; Keith R McCrae
Characterization of urokinase receptor expression by human placental trophoblasts.
Blood 1992;79(11):2917-29.
1992: V Novokhatny; Leonid Medved; Andrew P Mazar; Patrick A Marcotte; Jack Henkin; Kenneth C Ingham
Domain structure and interactions of recombinant urokinase-type plasminogen activator.
The Journal of biological chemistry 1992;267(6):3878-85.
1991: N M Hoosein; D D Boyd; W J Hollas; Andrew P Mazar; Jack Henkin; Leland W K Chung
Involvement of urokinase and its receptor in the invasiveness of human prostatic carcinoma cell lines.
Cancer communications 1991;3(8):255-64.
1990: Shafaat A Rabbani; J Desjardins; Alexander (Alex) Bell; Denis Banville; Andrew P Mazar; Jack Henkin; David Goltzman
An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells.
Biochemical and biophysical research communications 1990;173(3):1058-64.